Abstract
BACKGROUND: Currently, the negative role of asymptomatic hyperuricemia (HU) in the development and progression of cardiovascular pathology, metabolic disorders and chronic kidney disease is generally recognized. There is not much data in the literature on the effect of HU on the course of rheumatoid arthritis (RA), therefore, the study of the relationship of HU with clinical, radiological and immunological features of RA seems relevant.
 AIM: To study the relationship between HU with the clinical, radiological and immunological features of RA.
 MATERIALS AND METHODS: The data of 262 patients with RA and HU and 262 with RA without HU (comparison group) included in the city register from January 2000 to April 2020 have been analyzed. The information included demographic features (gender, age), diagnosis, presence and duration of HU, duration of observation, disease activity, laboratory, immunological, radiological and functional parameters, therapy of the underlying disease. HU was understood as a recorded 1-fold increase in the level of uric acid (UA) in the blood serum 360 mmol/l. The study has been approved by the local ethics committee.
 RESULTS: The data of 524 patients with rheumatoid arthritis for the period from January 2000 to April 2020 have been analyzed. The study included 440 women and 84 men. The average age of the patients was 60.0 13.6 y. The patients with HU have been divided into two subgroups: the first with the level of UA less than 500 mmol/l, the second with the level of UA more than 500 mmol/l. The number of males was significantly higher among the patients with high HU than among the patients with low HU and the comparison group. Every third patient had significant structural changes in the joints (radiological stage III-IV) and 98% of the patients had moderate and pronounced functional limitations (functional class 2-3). The patients with HU were older, had more follow-up visits, were observed for a longer period of time, had a lower frequency of radiological progression, a greater number of painful and swollen joints, less often and at a smaller dose had methotrexate and more often sulfasalazine in comparison with the patients without HU (p 0.05).
 CONCLUSIONS: 1) Thus, we can emphasize the negative impact of hyperuricemia on the course of rheumatoid arthritis: if it is present, there are direct (more PJ, SJ) and indirect signs of a more severe course (longer duration of observation and the number of visits). 2) Immunosuppressive therapy is associated with the absence of differences with the generally recognized markers of disease activity (ESR, CRP, DAS28), the immunological profile (RF, ACCP) and the ambiguous relationship with radiological progression and functional insufficiency of the joints, as well as unreliable relationship with a higher frequency of bone density reduction.
Highlights
The negative role of asymptomatic hyperuricemia (HU) in the development and progression of cardiovascular pathology, metabolic disorders and chronic kidney disease is generally recognized
2) Immunosuppressive therapy is associated with the absence of differences with the generally recognized markers of disease activity (ESR, CRP, DAS28), the immunological profile (RF, ACCP) and the ambiguous relationship with radiological progression and functional insufficiency of the joints, as well as unreliable relationship with a higher frequency of bone density reduction
Lee H.N., Kim A., Kim Y. et al Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis // Medicine (Baltimore). 2020
Summary
Клинико-иммунологические особенности сочетанного течения ревматоидного артрита и гиперурикемии. Одна ко в литературе недостаточно освещены особенности сочетанного течения гиперурикемии и ревматоидного артрита. В статистический анализ внесли сведения о демографических особенностях (пол, возраст) пациентов, диагнозе, наличии и длительности гиперурикемии, длительности наблюдения, активности и терапии ревматоидного артрита, а также его лабораторных, иммунологических, рентгенологических и функциональных характеристиках. Отсутствие взаимосвязи гиперурикемии с общепризнанными маркерами активности (скоростью оседания эритроцитов, уровнем С-реактивного белка, индексом DAS28) и иммунологическим профилем (ревматоидным фактором, позитивностью по антителам к циклическому цитруллинированному пептиду) ревматоидного артрита, а также ее неоднозначная взаимосвязь с его рентгенологической прогрессией, функциональной недостаточностью суставов и темпом снижения плотности костной ткани вызваны иммуносупрессивной терапией. Как цитировать: Мазуров В.И., Гайдукова И.З., Фонтуренко А.Ю., Башкинов Р.А., Петрова М.С., Инамова О.В. Клинико-иммунологические особенности сочетанного течения ревматоидного артрита и гиперурикемии // Вестник Северо-Западного государственного медицинского университета им.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: HERALD of North-Western State Medical University named after I.I. Mechnikov
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.